Effects of a single bout of interval hypoxia on cardiorespiratory control in patients with type 1 diabetes

Tobias Duennwald, Luciano Bernardi, Daniel Gordin, Anna Sandelin, Anna Syreeni, Christopher Fogarty, Janne P Kytö, Hannes Gatterer, Markku Lehto, Sohvi Hörkkö, Carol Forsblom, Martin Burtscher, Per-Henrik Groop, FinnDiane Study Group, Tobias Duennwald, Luciano Bernardi, Daniel Gordin, Anna Sandelin, Anna Syreeni, Christopher Fogarty, Janne P Kytö, Hannes Gatterer, Markku Lehto, Sohvi Hörkkö, Carol Forsblom, Martin Burtscher, Per-Henrik Groop, FinnDiane Study Group

Abstract

Hypoxemia is common in diabetes, and reflex responses to hypoxia are blunted. These abnormalities could lead to cardiovascular/renal complications. Interval hypoxia (IH) (5-6 short periods of hypoxia each day over 1-3 weeks) was successfully used to improve the adaptation to hypoxia in patients with chronic obstructive pulmonary disease. We tested whether IH over 1 day could initiate a long-lasting response potentially leading to better adaptation to hypoxia. In 15 patients with type 1 diabetes, we measured hypoxic and hypercapnic ventilatory responses (HCVRs), ventilatory recruitment threshold (VRT-CO2), baroreflex sensitivity (BRS), blood pressure, and blood lactate before and after 0, 3, and 6 h of a 1-h single bout of IH. All measurements were repeated on a placebo day (single-blind protocol, randomized sequence). After IH (immediately and after 3 h), hypoxic and HCVR increased, whereas the VRT-CO2 dropped. No such changes were observed on the placebo day. Systolic and diastolic blood pressure increased, whereas blood lactate decreased after IH. Despite exposure to hypoxia, BRS remained unchanged. Repeated exposures to hypoxia over 1 day induced an initial adaptation to hypoxia, with improvement in respiratory reflexes. Prolonging the exposure to IH (>2 weeks) in type 1 diabetic patients will be a matter for further studies.

Figures

FIG. 1.
FIG. 1.
Diagram of the study protocol, comprising measurements at t1, t2, t3, and t4. The intervention consisted of either 1) 6-min breathing of 13% oxygen mixture five times, each separated by 6-min recovery (IH) or 2) placebo exposure (breathing room air with 21% FiO2 for 1 h) in a single blind protocol. A standardized meal was given to the patients after t2 on both days. IH and placebo days were spaced at least 7 days apart.
FIG. 2.
FIG. 2.
Outline of the VRT-CO2 that illustrates the point at which the ventilation started to increase during the progressive HCVR. VRT-CO2 was identified by interpolating the ventilation/CO2-et plot using a fourth-order polynomial function. VE L/min, minute ventilation (liters/minute).
FIG. 3.
FIG. 3.
Plot shows changes in HCVR (top panel), VRT-CO2 (middle panel), and HVR (bottom panel) immediately after one single hour of IH or placebo exposure (n = 14). *Significant differences (P < 0.05, paired t test) from t1 to t2. Thick lines show mean values ± SEM.
FIG. 4.
FIG. 4.
Blood glucose changes over daytime on hypoxia day and placebo day. Measurements were performed at t1, t2, t3, and t4 after the hypoxic or placebo exposure (n = 15). Standardized meal was taken after t2 on both days (see indication). Blood glucose levels were compared with t1 of the same day. Data are presented as means ± SEM.

References

    1. Schönauer M, Thomas A, Morbach S, Niebauer J, Schönauer U, Thiele H. Cardiac autonomic diabetic neuropathy. Diab Vasc Dis Res 2008;5:336–344
    1. Bergner DW, Goldberger JJ. Diabetes mellitus and sudden cardiac death: what are the data? Cardiol J 2010;17:117–129
    1. Rosengård-Bärlund M, Bernardi L, Fagerudd J, et al. FinnDiane Study Group Early autonomic dysfunction in type 1 diabetes: a reversible disorder? Diabetologia 2009;52:1164–1172
    1. Boyko EJ, Ahroni JH, Stensel VL. Tissue oxygenation and skin blood flow in the diabetic foot: responses to cutaneous warming. Foot Ankle Int 2001;22:711–714
    1. Boulton AJ, Scarpello JH, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia 1982;22:6–8
    1. Solomon LR, Cohen K. Erythrocyte O2 transport and metabolism and effects of vitamin B6 therapy in type II diabetes mellitus. Diabetes 1989;38:881–886
    1. Wheatley CM, Baldi JC, Cassuto NA, Foxx-Lupo WT, Snyder EM. Glycemic control influences lung membrane diffusion and oxygen saturation in exercise-trained subjects with type 1 diabetes: alveolar-capillary membrane conductance in type 1 diabetes. Eur J Appl Physiol 2011;111:567–578
    1. Choudhury S, Taheri S. Obstructive sleep apnoea and type 2 diabetes: whose disease is it anyway? Practical Diabetes Int 2011;28:183–186
    1. Bernardi L, Rosengård-Bärlund M, Sandelin A, Mäkinen VP, Forsblom C, Groop PH, FinnDiane Study Group Short-term oxygen administration restores blunted baroreflex sensitivity in patients with type 1 diabetes. Diabetologia 2011;54:2164–2173
    1. Gordin D, Bernardi L, Rosengård-Bärlund M, et al. Oxygen increases arterial stiffness and blood pressure in patients with type 1 diabetes. Diabetologia 2011;54(Suppl. 1):493
    1. Neubauer JA. Invited review: Physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol 2001;90:1593–1599
    1. Casas M, Casas H, Pagés T, et al. Intermittent hypobaric hypoxia induces altitude acclimation and improves the lactate threshold. Aviat Space Environ Med 2000;71:125–130
    1. Rodríguez FA, Casas H, Casas M, et al. Intermittent hypobaric hypoxia stimulates erythropoiesis and improves aerobic capacity. Med Sci Sports Exerc 1999;31:264–268
    1. Burtscher M, Pachinger O, Ehrenbourg I, et al. Intermittent hypoxia increases exercise tolerance in elderly men with and without coronary artery disease. Int J Cardiol 2004;96:247–254
    1. Tin’kov AN, Aksenov VA. Effects of intermittent hypobaric hypoxia on blood lipid concentrations in male coronary heart disease patients. High Alt Med Biol 2002;3:277–282
    1. Meerson F, Pozharov V, Minyailenko T. Superresistance against hypoxia after preliminary adaptation to repeated stress. J Appl Physiol 1994;76:1856–1861
    1. Meerson FZ, Malyshev IYu, Zamotrinsky AV. Differences in adaptive stabilization of structures in response to stress and hypoxia relate with the accumulation of hsp70 isoforms. Mol Cell Biochem 1992;111:87–95
    1. Haider T, Casucci G, Linser T, et al. Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease. J Hypertens 2009;27:1648–1654
    1. Burtscher M, Haider T, Domej W, et al. Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD. Respir Physiol Neurobiol 2009;165:97–103
    1. Thake CD, Mian T, Garnham AW, Mian R. Leukocyte counts and neutrophil activity during 4 h of hypocapnic hypoxia equivalent to 4000 m. Aviat Space Environ Med 2004;75:811–817
    1. Nishimura M, Miyamoto K, Suzuki A, et al. Ventilatory and heart rate responses to hypoxia and hypercapnia in patients with diabetes mellitus. Thorax 1989;44:251–257
    1. Weisbrod CJ, Eastwood PR, O’Driscoll G, Green DJ. Abnormal ventilatory responses to hypoxia in Type 2 diabetes. Diabet Med 2005;22:563–568
    1. Williams JG, Morris AI, Hayter RC, Ogilvie CM. Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise. Thorax 1984;39:529–534
    1. Montserrat JM, Cochrane GM, Wolf C, Picado C, Roca J, Agusti Vidal A. Ventilatory control in diabetes mellitus. Eur J Respir Dis 1985;67:112–117
    1. Tantucci C, Scionti L, Bottini P, et al. Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest 1997;112:145–153
    1. Homma I, Kageyama S, Nagai T, Taniguchi I, Sakai T, Abé M. Chemosensitivity in patients with diabetic neuropathy. Clin Sci (Lond) 1981;61:599–603
    1. Heyman SN, Khamaisi M, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 2008;28:998–1006
    1. Thangarajah H, Yao D, Chang EI, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA 2009;106:13505–13510
    1. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999;26:259–265
    1. Behn C, Araneda OF, Llanos AJ, Celedón G, González G. Hypoxia-related lipid peroxidation: evidences, implications and approaches. Respir Physiol Neurobiol 2007;158:143–150
    1. Bernardi L, Gabutti A, Porta C, Spicuzza L. Slow breathing reduces chemoreflex response to hypoxia and hypercapnia, and increases baroreflex sensitivity. J Hypertens 2001;19:2221–2229
    1. Bernardi L, Passino C, Serebrovskaya Z, Serebrovskaya T, Appenzeller O. Respiratory and cardiovascular adaptations to progressive hypoxia; effect of interval hypoxic training. Eur Heart J 2001;22:879–886
    1. Spallone V, Bellavere F, Scionti L, et al. Diabetic Neuropathy Study Group of the Italian Society of Diabetology Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis 2011;21:69–78
    1. Laude D, Elghozi JL, Girard A, et al. Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol 2004;286:R226–R231
    1. Bernardi L, De Barbieri G, Rosengård-Bärlund M, Mäkinen VP, Porta C, Groop PH. New method to measure and improve consistency of baroreflex sensitivity values. Clin Auton Res 2010;20:353–361
    1. Veneskoski M, Turunen SP, Kummu O, et al. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a. Free Radic Biol Med 2011;51:834–843
    1. Meerson FZ, Ustinova EE, Orlova EH. Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia. Clin Cardiol 1987;10:783–789
    1. Tkatchouk EN, Gorbatchenkov AA, Kolchinskaya AZ, Ehrenburg I, Kondrykinskaya II. Adaptation to interval hypoxia with the purpose of prophylaxis and treatment. Hypoxia Med J 1994;11:308–328
    1. Lévy P, Pépin JL, Arnaud C, et al. Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives. Eur Respir J 2008;32:1082–1095
    1. Lavie L. Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 2003;7:35–51
    1. Calverley PM, Ewing DJ, Campbell IW, et al. Preservation of the hypoxic drive to breathing in diabetic autonomic neuropathy. Clin Sci (Lond) 1982;63:17–22
    1. Soler NG, Eagleton LE. Autonomic neuropathy and the ventilatory responses of diabetics to progressive hypoxemia and hypercarbia. Diabetes 1982;31:609–614
    1. Mahamed S, Cunningham DA, Duffin J. Changes in respiratory control after three hours of isocapnic hypoxia in humans. J Physiol 2003;547:271–281
    1. Pikkujämsä SM, Huikuri HV, Airaksinen KE, et al. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens 1998;11:523–531
    1. Takagi M, Tanaka Y, Yamasaki Y, et al. Responsiveness of insulin-induced cardiac sympathetic nerve activation associates with blood pressure regulation in diabetics. Am J Physiol Endocrinol Metab 2003;284:E1022–E1026
    1. Sakata S, Shimizu S, Kishi T, et al. Correlation between erythropoietin and lactate in humans during altitude exposure. Jpn J Physiol 2000;50:285–288
    1. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 2000;80:1055–1081
    1. Nieman DC. Exercise, infection, and immunity. Int J Sports Med 1994;15(Suppl. 3):S131–S141
    1. Stapleton PA, Goodwill AG, James ME, Brock RW, Frisbee JC. Hypercholesterolemia and microvascular dysfunction: interventional strategies. J Inflamm (Lond) 2010;7:54.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅